Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04950309 · ClinicalTrials.gov registry record · NA

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

A NA study of Normal Physiology, sponsored by National Institute of Mental Health (NIMH).

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT04950309: Recruiting NA study of Normal Physiology, sponsored by National Institute of Mental Health (NIMH).

NCT04950309 is a NA study of Normal Physiology that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 75 participants, below the 1,290-participant average among 25 other Normal Physiology trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04950309, a NA study of Normal Physiology, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Background: Brain activity produces magnetic fields. These fields can be measured outside the head. Existing technology, called MEG, measures these fields. Researchers are testing a new type of magnetic field sensor called OPM. They hope it can help pinpoint with very high accuracy where brain activity is generated. Objective: To develop and test a new type of sensor for measuring the magnetic fields produced by brain activity. Eligibility: Healthy people ages 18-65 who had a magnetic resonance imaging (MRI) scan under protocol 17-M-0181. Design: Participants may be asked to complete sessions on both the traditional MEG instrument and the OPM array. For the MEG, 3 small coils will be placed on the participant s face with tape. Their head will be positioned inside the MEG device. For the OPM, sensors are housed in a 3d printed array. The sensors will be attached to a cap placed on the participant s head. For both scans, participants will be seated in a chair inside a magnetically shielded room. They may complete several tasks. In one task, plastic cells will be placed on their fingers. Puffs of air will be sent to these cells, which will stimulate the sense of touch. Other tasks may include the following stimuli: visual (such as checkerboards), auditory (such as beeps and tones), or language (words and letters). Researchers may also obtain recordings while they stimulate the nerve in the participant s forearm using electrical current in small electrodes. Participation is expected to last for 1 day. Additional optional scans may be offered for up to 1 year....

Primary Outcome

At each phase of array construction characterization parameters including signal to noise, sensitivity, bandwidth, and spatial resolution will be measured.

Conditions Studied

Interventions

  • DEVICE SQUID MEG
  • DEVICE OPM MEG

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-05-12
Est. Completion 2026-08-01
Phase NA

What NCT04950309 shows while recruiting

NCT04950309 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,290-participant average among 25 other Normal Physiology trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 2 interventions - of which SQUID MEG is the first listed.

NCT04950309 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04950309 about?

NCT04950309 is a clinical study titled "Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array". Background: Brain activity produces magnetic fields. These fields can be measured outside the head. Existing technology, called MEG, measures these fields. Researchers are testing a new type of magnetic field sensor called OPM. They hope it can help pinpoint with very high accuracy where brain acti...

What is the current status of trial NCT04950309?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-05-12. Estimated completion is 2026-08-01.

What conditions does trial NCT04950309 study?

This clinical trial studies the following conditions: Normal Physiology.

What interventions are being tested in trial NCT04950309?

The interventions under investigation include: SQUID MEG (DEVICE), OPM MEG (DEVICE).

Who is sponsoring clinical trial NCT04950309?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04950309 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Physiology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04950309's enrollment target sits among peer trials

75 20th of 25 higher than 6 of 25 other Normal Physiology trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Normal Physiology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04950309, the US trial registry maintained by the National Library of Medicine. NCT04950309 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.